title: World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base.
abstract: The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis are a widely disseminated and used resource for information about anaphylaxis. They focus on patients at risk, triggers, clinical diagnosis, treatment in health care settings, self-treatment in the community, and prevention of recurrences. Their unique strengths include a global perspective informed by prior research on the global availability of essentials for anaphylaxis assessment and management and a global agenda for anaphylaxis research. Additionally, detailed colored illustrations are linked to key concepts in the text [Simons et al.: J Allergy Clin Immunol 2011;127:593.e1-e22]. The recommendations in the original WAO Anaphylaxis Guidelines for management of anaphylaxis in health care settings and community settings were based on evidence published in peer-reviewed, indexed medical journals to the end of 2010. These recommendations remain unchanged and clinically relevant. An update of the evidence base was published in 2012 [Simons et al.: Curr Opin Allergy Clin Immunol 2012;12:389-399]. In 2012 and early 2013, major advances were reported in the following areas: further characterization of patient phenotypes; development of in vitro tests (for some allergens) that help distinguish clinical risk of anaphylaxis from asymptomatic sensitization; epinephrine (adrenaline) research, including studies of a new epinephrine auto-injector for use in community settings, and randomized controlled trials of immunotherapy to prevent food-induced anaphylaxis. Despite these advances, the need for additional prospective studies, including randomized controlled trials of interventions in anaphylaxis is increasingly apparent. This 2013 Update highlights publications from 2012 and 2013 that further contribute to the evidence base for the recommendations made in the original WAO Anaphylaxis Guidelines. Ideally, it should be used in conjunction with these Guidelines and with the 2012 Guidelines Update.
authors.affiliation: Departments of Pediatrics and Child Health, and Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Man., Canada.
authors.forename: F Estelle R
authors.initials: FE
authors.lastname: Simons
authors.forename: Ledit R F
authors.initials: LR
authors.lastname: Ardusso
authors.forename: Vesselin
authors.initials: V
authors.lastname: Dimov
authors.forename: Motohiro
authors.initials: M
authors.lastname: Ebisawa
authors.forename: Yehia M
authors.initials: YM
authors.lastname: El-Gamal
authors.forename: Richard F
authors.initials: RF
authors.lastname: Lockey
authors.forename: Mario
authors.initials: M
authors.lastname: Sanchez-Borges
authors.forename: Gian Enrico
authors.initials: GE
authors.lastname: Senna
authors.forename: Aziz
authors.initials: A
authors.lastname: Sheikh
authors.forename: Bernard Y
authors.initials: BY
authors.lastname: Thong
authors.forename: Margitta
authors.initials: M
authors.lastname: Worm
mesh_terms: D000707:Anaphylaxis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D017410:Practice Guidelines as Topic